168 related articles for article (PubMed ID: 33003281)
1. An Investigation of Fibulin-2 in Hypertrophic Cardiomyopathy.
Ibrahim AM; Roshdy M; Elshorbagy S; Hosny M; Halawa S; Yehia D; Elfawy HA; Eldessouki A; Mohamed F; Ellithy A; Abdelfattah M; Elsawy A; Elkhatib M; Allouba M; Elguindy A; Aguib Y; Yacoub M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003281
[TBL] [Abstract][Full Text] [Related]
2. CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure.
Tsoutsman T; Wang X; Garchow K; Riser B; Twigg S; Semsarian C
J Mol Cell Cardiol; 2013 Sep; 62():164-78. PubMed ID: 23756156
[TBL] [Abstract][Full Text] [Related]
3. An insight of novel pharmacological therapies in hypertrophic cardiomyopathy.
Orenes-Piñero E; Hernández-Romero D; Jover E; de la Morena G; Valdés M; Marín F
Med Chem; 2011 Jul; 7(4):275-85. PubMed ID: 21568880
[TBL] [Abstract][Full Text] [Related]
4. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
[TBL] [Abstract][Full Text] [Related]
6. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts.
Schlittler M; Pramstaller PP; Rossini A; De Bortoli M
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834293
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.
Tsybouleva N; Zhang L; Chen S; Patel R; Lutucuta S; Nemoto S; DeFreitas G; Entman M; Carabello BA; Roberts R; Marian AJ
Circulation; 2004 Mar; 109(10):1284-91. PubMed ID: 14993121
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Hernández-Romero D; Orenes-Piñero E; García-Honrubia A; Climent V; Romero-Aniorte AI; Martínez CM; García-Bautista M; Martínez M; Feliu E; González J; Cánovas S; Montero-Argudo JA; Valdés M; Marín F
J Intern Med; 2015 Jul; 278(1):50-8. PubMed ID: 25476756
[TBL] [Abstract][Full Text] [Related]
9. Scleraxis as a prognostic marker of myocardial fibrosis in hypertrophic cardiomyopathy (SPARC) study.
Zhu A; Bews H; Cheung D; Nagalingam RS; Mittal I; Goyal V; Asselin CY; Kirkpatrick IDC; Czubryt MP; Jassal DS
Can J Physiol Pharmacol; 2020 Jul; 98(7):459-465. PubMed ID: 32027517
[TBL] [Abstract][Full Text] [Related]
10. Imaging cardiac morphology in hypertrophic cardiomyopathy: recent advances.
Reichek N
Curr Opin Cardiol; 2015 Sep; 30(5):461-7. PubMed ID: 26154073
[TBL] [Abstract][Full Text] [Related]
11. Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast Activation.
Shih YC; Chen CL; Zhang Y; Mellor RL; Kanter EM; Fang Y; Wang HC; Hung CT; Nong JY; Chen HJ; Lee TH; Tseng YS; Chen CN; Wu CC; Lin SL; Yamada KA; Nerbonne JM; Yang KC
Circ Res; 2018 Apr; 122(8):1052-1068. PubMed ID: 29535165
[TBL] [Abstract][Full Text] [Related]
12. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
[TBL] [Abstract][Full Text] [Related]
13. Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy.
Rixon C; Andreassen K; Shen X; Erusappan PM; Almaas VM; Palmero S; Dahl CP; Ueland T; Sjaastad I; Louch WE; Stokke MK; Tønnessen T; Christensen G; Lunde IG
ESC Heart Fail; 2023 Apr; 10(2):858-871. PubMed ID: 36444917
[TBL] [Abstract][Full Text] [Related]
14. Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.
Marian AJ; Tan Y; Li L; Chang J; Syrris P; Hessabi M; Rahbar MH; Willerson JT; Cheong BY; Liu CY; Kleiman NS; Bluemke DA; Nagueh SF
Circ Res; 2018 Apr; 122(8):1109-1118. PubMed ID: 29540445
[TBL] [Abstract][Full Text] [Related]
15. Characterization and quantitation of extracellular collagen matrix in myocardium of pigs with spontaneously occurring hypertrophic cardiomyopathy.
Chiu YT; Liu SK; Liu M; Chen SP; Lin YH; Mao SJ; Chu R
Cardiovasc Pathol; 1999; 8(3):169-75. PubMed ID: 10722240
[TBL] [Abstract][Full Text] [Related]
16. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK
Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040
[TBL] [Abstract][Full Text] [Related]
17. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
[TBL] [Abstract][Full Text] [Related]
18. Altered regional myocardial velocities by tissue phase mapping and feature tracking in pediatric patients with hypertrophic cardiomyopathy.
Li A; Ruh A; Berhane H; Robinson JD; Markl M; Rigsby CK
Pediatr Radiol; 2020 Feb; 50(2):168-179. PubMed ID: 31659403
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy.
Gastl M; Gruner C; Labucay K; Gotschy A; Von Spiczak J; Polacin M; Boenner F; Kelm M; Ruschitzka F; Alkadhi H; Kozerke S; Manka R
Open Heart; 2020; 7(1):e001152. PubMed ID: 32201584
[TBL] [Abstract][Full Text] [Related]
20. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
